Strainsforpains PEG
PEG Ratio (Price/Earnings-to-Growth) of Strainsforpains (EBYH) as of Jul 30, 2026.
Get this data via API
Financial Data API
PEG
0.00
Last updated:
PEG Ratio (Price/Earnings-to-Growth) of Strainsforpains is 2026 0.00 . PEG Ratio (Price/Earnings-to-Growth) of Strainsforpains was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
Strainsforpains Stock analysis
What does Strainsforpains do? Strainsforpains Inc - A Story of Pain Relief and Healing
Strainsforpains Inc was founded in 2010 by a team of experienced doctors, scientists, and cannabis enthusiasts. The idea behind the company was to provide people with alternative and effective solutions for pain and illnesses that had not been well treated with conventional medications.
The business model of Strainsforpains Inc has always been based on the use of medical marijuana, which can provide significant relief and healing for numerous conditions such as chronic pain, depression, epilepsy, and nausea. The company focused on comprehensive research and scientific studies to develop and breed the best marijuana strains for various medical applications.
Strainsforpains Inc operates several divisions that cater to the different needs of patients and customers. The main division is the sale of medical marijuana for people with conditions such as cancer, chronic pain, and uncontrollable tremors. The company works with licensed marijuana breeders and growers to produce a wide range of strains suitable for different applications and preferences.
Another division of Strainsforpains Inc is the production of medical marijuana products available in various forms such as oils, tinctures, capsules, and lozenges. These products are made from high-quality, pure marijuana extract and are intended for people who do not prefer smoking or vaporizing cannabis flowers or for whom smoking is not appropriate.
In recent years, Strainsforpains Inc has also launched a division for recreational marijuana, targeting people who consume marijuana for recreational purposes. The company offers a wide range of strains and products and aims to upgrade the recreational marijuana market by offering healthy and high-quality products.
However, the company has not only found success in the medical industry but also in the beauty industry. Strainsforpains Inc has its own division for hemp products that are integrated into the company's skincare products. Hemp oil is rich in antioxidants, anti-inflammatory properties, and moisturizing properties. The products from Strainsforpains Inc are ideal for people who want to fight skin problems such as acne or psoriasis.
In conclusion, Strainsforpains Inc is an innovative company that quickly established itself in the market with its focus on alternative medicine and hemp products, helping many people in their healing process. With its comprehensive range of different marijuana strains and products and its focus on medical applications and alternative therapies, the company has provided many patients and customers with a chance for healing and pain relief. Strainsforpains is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Strainsforpains stock
On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Strainsforpains since 2006 – with annual values, charts, and detailed analysis.
Access this data via the Eulerpool API
Valuation — Strainsforpains
All Key Metrics — Strainsforpains
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth